results INVESTMENT CREATES
Pulmonary Fibrosis Foundation 2011 ANNUAL REPORT
Moving our cause forward requires transition, growth, and achievement. Focused on our mission, the Foundation is unyielding in our journey to grow and make a positive impact. With our investments and those of our supporters, we look at how we created unprecedented results.
Dear Friends,
The Foundation is dedicated to supporting research; the PFF Research Program consists of complementary efforts designed to foster innovation.
It was over eleven years ago when my father and his brother founded the
In 2011, we added four grant awards to the PFF Research Fund. These
Pulmonary Fibrosis Foundation (PFF). Their goal was to help those affected
grants — the Young Investigator and Established Investigator Awards —
by pulmonary fibrosis (PF). I’m proud to say that today’s Foundation has
are given over a two-year period. All grant applications are reviewed by our
evolved from a family foundation into a truly international patient advocacy
Research Advisory Committee. One objective of the Committee is to identify
organization. In 2011, the Foundation made significant strides in advancing
key gaps in basic and clinical knowledge that may impede the development
the core pillars of our mission.
of successful treatments. These “bridge grants” play a vital role in supporting
Last year we achieved a milestone when we presented the IPF Summit 2011: From Bench to Bedside — our inaugural scientific conference and our most
investigators at a crucial time and can provide the needed data to secure larger, federal grants.
ambitious initiative up to that time. The Summit featured a world-class
I am extremely appreciative for all the help we received in 2011. I would
faculty that included sessions for physicians, researchers, nurses, allied
like to especially thank the Foundation staff led by Chief Operating Officer
health care personnel, patients, and caregivers. Representatives from the
Patti Tuomey. Patti’s team made this groundbreaking year a reality, and
biotechnology, pharmaceutical, and investment communities were also in
I salute their tireless effort and dedication. I must also stress the importance
attendance. This provided a unique opportunity for collaboration with some
of the entire PF community — individual donors, corporate sponsors, and
of the major stakeholders who are working to find a cure for this disease.
volunteers who all help us achieve our goals — thank you. We would not be
The curriculum that was presented at the Summit will help contribute
able to do what we do without your support. Our job is far from over and I am
to improving diagnosis, providing better patient care, and stimulating new
certain you’ll continue to support us in the fight against this deadly disease.
research. Our Summit in 2013 is guaranteed to be just as innovative.
Sincerely,
Daniel M. Rose, MD PRESIDENT AND CHIEF EXECUTIVE OFFICER
To Our Community, For a young organization with bold and important goals, it is vital that we optimize our opportunities to grow and make an impact. In 2011, we invested time, energy, and resources into initiatives that truly enabled
Another highlight of last year was our tenth anniversary New Decade,
us to help advance our mission. These efforts culminated in the success
New Reach dinner. Held in tandem with the Summit , over 300 people came
of our inaugural, international health care conference — IPF Summit 2011:
together at The Field Museum of Natural History to recognize our achieve-
From Bench to Bedside — and highlighted a year of achievement,
ments and honor those whose tireless work made them a reality. It was
growth, and results.
a remarkable evening, filled with laughter and tears. We reflected on our
It was our President and CEO, Daniel M. Rose, MD, who had the vision to create a biennial IPF Summit . As a medical professional he knew the
previous successes and contemplated some of our ambitious plans for the next decade.
importance of such an ambitious endeavor. In successfully executing
Last year was a milestone in our history. I have great appreciation for
the Summit , the Foundation has made a distinctive leap forward and we
our founders and their work that we continue today. The Pulmonary Fibrosis
have firmly established ourselves as an important international resource
Foundation is more than any one person or team. I thank our tireless and
for the pulmonary fibrosis (PF) community. IPF Summit 2011: From Bench
dedicated staff for their commitment to results. And I applaud our volunteers
to Bedside , held in Chicago December 1–3, had the largest scope and
— our Board, medical advisors, and fundraisers. Every day they demonstrate
reach of any Foundation initiative. We invested significant resources to
a personal obligation to the community we serve. Our investment in 2011 truly
add integral infrastructure and key staff in patient relations, development,
created results and set the stage for greater impact in 2012 and beyond.
marketing, and finance to present the three-day, multi-faceted program. Additionally, the Summit set into motion opportunities for collaboration
Sincerely,
that will greatly benefit the entire PF community. Patti Tuomey, EdD CHIEF OPERATING OFFICER
2
PULMONARY FIBROSIS FOUNDATION
About the Disease WHAT DOES THE DISEASE LOOK LIKE?
WHAT IS PULMONARY FIBROSIS AND WHAT ARE THE CAUSES? Pulmonary fibrosis (PF) is a progressive, fatal condition in which the lung tissue becomes thickened, stiff, and fibrotic (scarred). As the scarring progresses, the lungs lose their ability to transfer oxygen, and the brain and other organs don’t receive the adequate oxygen needed to function properly. Pulmonary fibrosis can be the result of exposure to certain environmental agents (dust, silica), medications (antibiotics, antiarrhythmics), radiation, autoimmune diseases (scleroderma, rheumatoid arthritis), or a genetic
IPF affects approximately 200,000 individuals
Symptoms include:
in the United States with an estimated annual
• Shortness of breath (dyspnea)
mortality of 40,000. As a result of the difficulty
• Chronic dry, hacking cough
in making a diagnosis and lack of a national
• Fatigue and weakness
surveillance registry, the accrual of accurate
• Discomfort in the chest
data has been problematic. For these reasons
• Loss of appetite
it has also been difficult to obtain adequate data
• Weight loss
regarding the incidence of those affected by pulmonary fibrosis from all causes.
Treatment includes supplemental oxygen, respiratory therapy, maintaining a healthy lifestyle
predisposition. However, in most situations the etiology is unknown. If there
IPF has no strong demographic profile although
(optimizing weight and exercise), and for those
is no known cause, then the disease is called idiopathic pulmonary fibrosis
it appears to affect more men than women.
who qualify, lung transplantation.
(IPF). There is no cure for IPF, and there is no FDA-approved treatment
The median age at the time of diagnosis is
for IPF in the United States. Extremely limited therapeutic options for IPF
approximately 63 years; however, the disease
are available in the European Union and Asia.
affects individuals of all ages.
Pulmonary fibrosis is a devastating disease. It is our goal to help find effective treatments and ultimately a cure. Until that time, we aspire to raise awareness, help educate the professional and patient communities, promote patient and legislative advocacy, and provide support to patients, family members, and caregivers.
2011 ANNUAL REPORT
3
In 2011, the Pulmonary Fibrosis Foundation made our greatest single investment in advancing education, fostering collaboration, and increasing awareness of pulmonary fibrosis. It was the vision of our President and CEO, Daniel M. Rose, MD, to host an
The Summit featured innovative continuing medical
international scientific conference to facilitate these initiatives and to identify
education programs for physicians, researchers,
new approaches to treat and ultimately find a cure for idiopathic pulmonary
registered nurses, and allied health professionals
fibrosis (IPF). Our inaugural biennial conference, IPF Summit 2011: From
to improve their understanding of PF. In addition,
Bench to Bedside , was the culmination of over two years of planning and
there was a one-day program to address the growing
preparation, and its success set into motion opportunities that will greatly
educational needs of patients, family members,
benefit the pulmonary fibrosis (PF) community.
and caregivers. Sessions were led by a world-class faculty and are available as on demand webinars through our website.
4
PULMONARY FIBROSIS FOUNDATION
inspiring collaboration The Summit was planned in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education, in partnership with The France Foundation and National Jewish Health, and was endorsed by the American Thoracic Society. Clinical and scientific objectives for the Summit were identified in a needs assessment. Following completion of the medical sessions participants were able to:
REACHING THE PF COMMUNITY • Explain the pathophysiology of IPF based on the most current data
IPF SUMMIT 2011 ATTENDANCE STATISTICS
• Accurately diagnose IPF using a systematic approach
Medical Professionals
244
• Effectively implement key diagnostic procedures including HRCT
Patients and Caregivers
127
scanning and surgical lung biopsy • Discuss recent evidence for treatments in the management of IPF • Recognize genetic components of IPF
States Represented
36
Countries Represented
14
Satellite Viewing Groups
225 viewers at
• Describe the role of lung transplantation in IPF and the factors
10 national and
that affect candidacy and timing
3 international
• Provide patient lifestyle management tools that improve functional status
satellite locations
• Develop a comprehensive approach to the management of IPF that
Live Webcast Viewers
600 viewers in
includes both pharmacologic and non-pharmacologic therapies
9 countries
2011 ANNUAL REPORT
5
THE SUMMIT FACULTY SUPPORTING NEW RESEARCH IPF Summit 2011: From Bench to Bedside emphasized the importance of new research;
twenty-six young academic investigators were chosen to give poster presentations on their basic, clinical, translational, or social science/quality of life research. All submissions were peer-reviewed and graded; awards were given for the first, second, and third place posters. 1st Place Jonathan Kropski, MD VANDERBILT UNIVERSITY
“Herpes Virus Infection Exacerbates Endoplasmic-Reticulum Stress and Acts as a ‘Second-Hit’ in the Development of Lung Fibrosis”
KENNETH ADLER, PhD
CHRISTINE KIM GARCIA, MD, PhD
North Carolina State University
University of Texas
JOHN DAVID ARMSTRONG II, MD, MA
CHARLES HOOPES, MD
National Jewish Health
University of Kentucky College of Medicine
BRIAN BAIRD, MS, PhD
ALIYA N. HUSAIN, MD
Former U.S. Representative to Congress
University of Chicago
RITU S. BARAL
SUSAN S. JACOBS, RN, MS
CANACCORD Genuity
Stanford University
TIMOTHY S. BLACKWELL, MD
MIRANDA G. JAMES, Esq
Honorable Mentions
Vanderbilt University Medical Center
Caring Voice Coalition
Stephenie Takahashi, MD
WILLIAMSON BRADFORD, MD, PhD
NAFTALI KAMINSKI, MD
UNIVERSITY OF CHICAGO
InterMune, Inc.
University of Pittsburgh School of Medicine
KEVIN K. BROWN, MD
DOLLY KERVITSKY, RCP, CCRC
National Jewish Health
Pulmonary Fibrosis Foundation
HAROLD R. COLLARD, MD
TALMADGE E. KING, Jr., MD
University of California
“The Inhibitory Molecule, BTLA, Regulates Pulmonary Fibrosis in a Mouse Model”
2nd Place
Anand Iyer, MD
University of California
Adam Booth, PhD
HAMPTON UNIVERSITY SCHOOL
GREGORY P. COSGROVE, MD
JOSEPH LASKY, MD
UNIVERSITY OF MICHIGAN
OF MEDICINE
National Jewish Health
Tulane University
BRENDA CROWE, CRT
KATHLEEN LINDELL, PhD, RN
Exempla Lutheran Medical Center
University of Pittsburgh
ARYEH FISCHER, MD
BRONWYN LONG, DNP, MBA, RN
National Jewish Health
National Jewish Health
“Fibroblast Responses to Decellularized Human
“Angiogenic Mediators Regulate Single-Walled
Lung Slices Implicate the Extracellular Matrix
Carbon Nanotube-Induced Fibrogenesis in
in Directing Fibroblast Phenotypes”
Human Lung Fibroblasts”
University of Colorado
3rd Place Adita Mathur, MD YALE UNIVERSITY
“Role of Semaphorin 7a in Lymphocytes in TGF-ß Driven Lung Fibrosis”
6
PULMONARY FIBROSIS FOUNDATION
KEVIN R. FLAHERTY, MD, MS
University of Michigan Health System
ROBERT B. LOVE, MD
Loyola University Medical Center
MARIANNE MANN, MD
MARVIN I. SCHWARZ, MD
Consultant, Washington, DC
University of Colorado
FERNANDO J. MARTINEZ, MD, MS
MARK SHREVE
University of Michigan
Pulmonary Fibrosis Foundation
WENDI R. MASON, MSN, ACNP-BC
JEFFREY J. SWIGRIS, DO, MS
Vanderbilt University Medical Center
University of Colorado
disease to the Foundation. Ms. Kervitsky played a key role in developing the programming
KENNETH R. McCURRY, MD
ANDREW TAGER, MD
for the patient and caregiver sessions at the IPF Summit 2011: From Bench to Bedside .
Cleveland Clinic
Harvard Medical School
The sessions were:
A. BRUCE MONTGOMERY, MD
JANET TALBERT, MS, CGC
• What is Pulmonary Fibrosis (PF) and
Cardeas Pharma
National Jewish Health
What are the Causes?
IMRE NOTH, MD
SHELIA VIOLETTE, PhD
University of Chicago
Stromedix
GANESH RAGHU, MD
GAIL G. WEINMANN, MD
University of Washington Medical Center
National Heart, Lung, and Blood Institute
JESSE ROMAN, MD
TIMOTHY P. WHELAN, MD
University of Louisville
Medical University of South Carolina
GLENN D. ROSEN, MD
ERIC S. WHITE, MD
Stanford University School of Medicine
University of Michigan Health System
DAVID A. SCHWARTZ, MD
DAVID A. ZISMAN, MD, MS
University of Colorado Medical Center
Sansum Clinic
DOLLY KERVITSKY JOINS THE PFF TEAM Dolly Kervitsky, RCP, CCRC, joined the Foundation in February 2011 as the Vice President of Patient Relations. She brings 30 years of experience and expertise in interstitial lung
• What are the Symptoms of Pulmonary Fibrosis
and What are the Treatment Options? • Lung Transplantation • Familial PF and Genetic Counseling • Pulmonary Rehabilitation • Establishing a Support Group • The Why, How, and What of Clinical Trials • Advocacy • Navigating Medicare and Health Insurance • Managing Advanced Disease and Hospice Care • Living with PF and How to Improve Quality of Life • Roundtable Discussions with the Experts
2011 ANNUAL REPORT
7
About Dolly Kervitsky Dolly Kervitsky, RCP, CCRC, began her respiratory therapy career as a Staff Respiratory Therapist in the Medical, Pediatric, and Burn and Trauma Intensive Care Units at the University of New
In 1983, she began working with pulmonary fibrosis patients and researchers
Mexico. In 1981, she joined National Jewish
as the Clinical Coordinator for the Specialized Center of Research investigating
Health (NJH) as a Staff Respiratory Therapist;
idiopathic pulmonary fibrosis, funded by the National Institutes of Health (NIH).
Over 950 patients and caregivers attended the
in 1982, she was named Acting Director of the
The NIH project was instrumental in the development of the Interstitial and
Summit in person and via webcast. The sessions
Respiratory Therapy Department.
Autoimmune Lung Disease Program at NJH where Ms. Kervitsky was named
were archived as webinars and are available at www.pulmonaryfibrosis.org/summit.
the Program Manager in 1992. In 2008, Ms. Kervitsky founded the Genetic Counseling Program for Familial
In less than ten months at the Foundation,
Pulmonary Fibrosis at NJH. She has served as a lead coordinator and steering
Ms. Kervitsky has set into motion major initiatives
committee member for several international multi-center research trials.
that will benefit the PF community in 2012 and
Additionally, she is a member of the American Thoracic Society, American
beyond. The Foundation is thrilled to have her
College of Chest Physicians, Association of Respiratory Care, and Association
on our team.
of Clinical Research Professionals.
8
PULMONARY FIBROSIS FOUNDATION
recognizing passion The dinner’s theme, New Decade, New Reach:
We came together to commemorate our ten-year anniversary during a special evening
Together We Will Make a Difference , truly reflects
at The Field Museum of Natural History in Chicago.
today’s Foundation. The evening was strategically timed so that the many different stakeholders
The Pulmonary Fibrosis Foundation (PFF) began as a family
that came to Chicago to attend the Summit could
foundation with the noble goal of finding a cure for pulmonary
attend the dinner as well. We take pride in facilitating
fibrosis. Just ten years later, we have evolved into a leading
relationship building, and the dinner was such
international organization fighting this devastating disease through
an opportunity. Old friends were reunited and new
important initiatives such as the Summit and our PFF Research
connections were made with everyone sharing
Program. Over the course of the evening we honored those who
a common bond of winning the fight against
have been instrumental in our growth and presented our vision
pulmonary fibrosis.
for the future.
The Foundation thanks our dinner co-chairs, speakers, emcee Mary Ann Ahern, and our dedicated staff for making the New Decade, New Reach dinner a tremendous success. The evening
was a fitting tribute to the legacy we carry forward. We have our eye on the future and are focused on fulfilling our mission.
2011 ANNUAL REPORT
9
fostering innovation The Pulmonary Fibrosis Foundation places great importance on creating an environment that will assist in the development of effective treatments for pulmonary fibrosis. In 2011, we invested in research through multiple avenues.
BUILDING KEY RELATIONSHIPS
The Foundation actively fostered relationships and opportunities to enhance research and drug
10
DIRECTLY FUNDING RESEARCH
ADVOCATING FOR LEGISLATION
development. We collaborated with other important
The Foundation funded important peer-reviewed
We regularly communicated with members
organizations such as the National Heart, Lung, and
research through our PFF Research Program.
of Congress and their legislative aides to lobby
Blood Institute (NHLBI); the National Organization
All grant requests underwent rigorous review by
for the passage of legislation important to
for Rare Disorders (NORD); the Food and Drug
members of the Research Advisory Committee
the PF community. We also provided resources,
Administration (FDA); and have worked closely
(RAC) under the direction of Jesse Roman, MD.
information, and tools for our constituents to
with other disease-specific organizations to
The RAC decided which projects would provide
contact their legislators and to promote disease
advance best practices and work on common
the best opportunities to advance research.
awareness in their community.
advocacy issues.
PULMONARY FIBROSIS FOUNDATION
ABOUT THE PFF YOUNG INVESTIGATOR AND ESTABLISHED INVESTIGATOR AWARDS In November of 2011, the Foundation established our Young Investigator and Established Investigator Awards that
FOSTERING INNOVATION
are offered through the PFF Research Fund. These grants
The Foundation conducted educational programs
play a vital role in supporting investigators at a critical time
such as the IPF Summit 2011: From Bench to
in the research process. Referred to as “bridge grants,” these
Bedside to foster a collaborative environment
funds provide support for the investigator to accrue enough
for improved understanding of PF and to provide
research documentation to secure larger grants.
a forum for discussions regarding development
PATIENT COMMUNICATIONS
of effective therapies. We also provided support
It is critical for patients to be able to advocate
The program awards two Young Investigator and two
for other organizations’ meetings, colloquia, and
for, and participate in, their own health care.
Established Investigator grants per year, each given over
seminars through partnerships and sponsorships.
Our patient communications were increased and
a two-year period:
These platforms offered opportunities for profes-
standardized in 2011 and are an excellent resource
sionals to expand their knowledge of PF, engage
for patients, family members, and caregivers to
with thought leaders in PF, and partner in
learn about clinical trials, research, safety issues,
drug development.
and advocacy efforts.
Young Investigator Awards $50,000 grant designed to encourage young investigators
(individuals within five years of completion of their formal training) to maintain and enhance their interest in PF research during the early stages of their academic career. Established Investigator Awards $50,000 grant designed to help established investigators
explore innovative areas of research that may not yet be eligible for a federal grant.
2011 ANNUAL REPORT
11
2011 GRANT COMMITMENTS In 2011, the Pulmonary Fibrosis Foundation solely or jointly funded twelve grants. Award recipients were: PFF RESEARCH FUND
ATS / PFF / CPF PARTNERSHIP GRANTS
2011 SPONSORSHIPS
• Dr. Erica Herzog of Yale University –
• Dr. Erica Herzog of Yale University – “Semaphorin 7a and Alternative
• UC Davis Medical Center; University of California,
Macrophage Activation in Idiopathic Pulmonary Fibrosis”
San Francisco; and Stanford University Medical
• Dr. Steven Huang of University of Michigan – “The Regulation and
Center – Understanding Pulmonary Fibrosis:
Pattern of the DNA Methylome in Pulmonary Fibrosis”
A Seminar for Patients, Caregivers, and Families
in Lung Transplant Recipients” (Year 2)
• Dr. Philip Simonian of University of Colorado Denver – “Protection from
• National Jewish Health – Familial Pulmonary
• Dr. Daniel J. Kass and Dr. Naftali Kaminski of
Inflammation-Induced Pulmonary Fibrosis by IL-22”
Fibrosis Genetic Counseling Program
University of Pittsburgh – “Targeting the Relaxin
• Dr. Beiyun Zhou of University of Southern California – “Endoplasmic
• Pittsburgh International Lung Conference
Pathway in Pulmonary Fibrosis”
Reticulum Stress Induces Epithelial-Mesenchymal Transition in Alveolar
• Yale University – Fifth Annual Symposium
• Dr. Imre Noth of University of Chicago –
Epithelial Cells: Role in Pulmonary Fibrosis”
on Nephrogenic Systemic Fibrosis and Allied
ATS / PFF INTERNATIONAL PARTNERSHIP GRANT
Systemic Fibrosing Disorders
“Prospective Evaluation of IPF Biomarkers” • Dr. Aldo T. Iacono of University of Maryland –
“Open Label Use of Inhaled Cyclosporine
“miRNA Expression in Patients with Rapidly Progressive IPF Versus Stable IPF” (Year 1) • Dr. Patricia J. Sime of University of Rochester –
“Translational Studies of New Therapeutic Targets & Biomarkers in PF”
• Anne Holland, PhD of La Trobe University, Australia – “Where Does
Pulmonary Rehabilitation Fit in the Management of Pulmonary Fibrosis?” ATS / PFF / CPF YOUNG INVESTIGATOR PARTNERSHIP GRANTS • Dr. Jia Guo of University of Rochester – “Fibrocyte Differentiation
is Regulated by Yin Yang 1 in Pulmonary Fibrosis” • Dr. Yan Sanders of University of Alabama at Birmingham – “Epigenetic
Regulation of Caveolin-1 by TGF-ß Mediated Signal Pathway in Lung Fibroblasts”
12
PULMONARY FIBROSIS FOUNDATION
empowering voices To raise awareness and increase support for patients and families affected by pulmonary fibrosis, the Pulmonary Fibrosis Foundation invested in strategic legislative initiatives in 2011. Most significantly, we focused on the Pulmonary
The PFREA was re-introduced into the 112 th
Additionally, we introduced CQ Roll Call, a web
Fibrosis Research Enhancement Act ( S. 1350,
Congress in the summer of 2011, supported by
tool that allowed the PFF community to directly
H.R. 2505 ) or PFREA. The PFREA requests
a bipartisan group of Senators — Christopher
request support for the PFREA from their district
Congress to set up a national pulmonary fibrosis
Coons (D-DE), Mark Kirk (R-IL), Michael Crapo
representatives.
(PF) surveillance registry, create an advisory board,
(R-ID), and Patty Murray (D-WA) — along with
and establish an education and awareness plan.
House Representatives Erik Paulsen (R, MN-3)
The PFREA also encourages the National Institutes
and Tammy Baldwin (D, WI-2).
of Health to “expand, intensify, and coordinate” their activities and research in PF.
Through meetings with potential sponsors, grassroots initiatives, awareness campaigns, and partnerships with other organizations including
During IPF Awareness Week 2011, members
the Pulmonary Fibrosis Advocates and the
of our staff and other advocates from the PFF
Coalition for Pulmonary Fibrosis, the Foundation
community traveled to Capitol Hill to meet with
helped acquire the support of 71 co-sponsors in
legislators and gain support for the PFREA.
the House and 13 co-sponsors in the Senate.
2011 ANNUAL REPORT
13
expanding community It is through the actions of those impacted by pulmonary fibrosis — and the passionate, dedicated advocates who share their stories with the world — that strides in raising awareness are made. Songs for Mike: A Benefit Evening Honoring Michael Kuchwara tells such a story. Julie Halston, renowned Broadway actress, already intimately knew the dire implications of a diagnosis of idiopathic pulmonary fibrosis (IPF) when she heard that her friend Michael Kuchwara had the disease. Julie’s husband, radio personality Ralph Howard, underwent a lung transplant due to IPF in 2010. Now Julie was touched by this devastating disease a second time.
14
PULMONARY FIBROSIS FOUNDATION
Michael Kuchwara’s story is like that of so many others. With no previous illness, the disease struck Mr. Kuchwara unexpectedly and in the prime of his life. He had been the Associated Press theater critic for many years and was widely respected and loved by those in front of, and behind, the Broadway curtain. His death in May 2010 from complications of IPF was a shock to
New York’s theater community and Julie Halston’s call to action.
Hosted by Julie with her impeccable wit and comedic skills, Songs for Mike was held at New York’s renowned jazz club Birdland on February 28, 2011. A tremendous success,
Julie had never heard of pulmonary fibrosis
the night featured over a dozen Broadway stars,
before her husband’s diagnosis and she was
and culminated with a surprise appearance by
Songs for Mike was just the first of what is now an annual Broadway-
stunned to hear that Michael Kuchwara also
Broadway legend and movie star Liza Minnelli.
inspired signature event for the Foundation. It will continue to bring people
suffered from the disease. To honor the memory
Songs for Mike raised $40,000 for the Michael
together in this fight and move our shared cause forward. We thank the
of her dear friend, and to raise awareness of the
Kuchwara Fund benefitting the Pulmonary Fibrosis
dedicated volunteers who tirelessly work to increase awareness of the
disease, she collaborated with mutual friends
Foundation, and enhanced the Foundation’s
disease and raise money to fund support services and research.
D. Michael Dvorchak, Ed Windels, and Sue Frost
work to spread much needed awareness of this
Together we will help find a cure.
to create a musical tribute to Kuchwara. Michael’s
little-known disease.
memory in an evening of song that showcased the music he loved so much.
PHOTOS BY CHRIS OW YOUNG
friends, and the stars of Broadway, honored his
2011 ANNUAL REPORT
15
Thank you to all of our donors for investing in us. 2011 SUPPORTERS $100,000+
RS Family Trust
$2,500–$4,999
Frank Sica
Paul & Susan Bergna
Sandra & Thomas Kully
Richard & Robin Schottenfeld
Anonymous
Sioux Falls Area Community Foundation
William J. Boucher
Charles & Monica McQuaid
Thelma K. Stephenson
Alice C. Petinge Memorial Fund
Stromedix, Inc.
Sally Boyer
Gerda Tighe
American Recycling &
Sue Tarr
David Brown
Lisa Tighe
Thomas & June Butkovich
$10,000–$99,999 Acra Aerospace, Inc. Donald Bickel Boat Works Bar and Grill Boehringer Ingelheim Pharmaceuticals, Inc.
Campbell Scientific, Inc.
Judy Tighe Dooley
Caffarelli & Siegel Ltd.
Ziff Brothers Investments
William Clotworthy, Jr., MD
John Tighe II
Angelina Caldwell
Daryl and Steven Roth Foundation
Patricia Townsend
Michael & Nancy Callahan
Disney Worldwide Services, Inc.
Stephen A. Wald, PhD
Susan Campbell
Paul Fogelberg
Washers for Wellness
Catholic Communal Fund of
$5,000–$9,999 Elissa Aronwald Sandra Bean Lewis
Coalition for Pulmonary Fibrosis
George Bergna
Phyllis Demont
Broadway Cares/Equity Fights AIDS
The Gordon & Llura Gund Foundation
Stephen Bunzl
Thomas & Alice Hales
Cheryl A. & John M. O’Meara Charitable Foundation
InterMune
Pamela Choney
Jenny H. Krauss & Otto F. Krauss
GE Foundation Matching Gifts Program
Charitable Foundation JP ’s Peace, Love, & Happiness
Foundation
Suzanne Gylfe The Joan N. and Francis M. Austin, Jr. Foundation, Inc.
Pete DeVito Memorial Foundation
John Larmer
Promedior, Inc.
Patterson Companies, Inc.
Respiratory Health Association
Rail-Splitter Capital Management, LLC
of Metropolitan Chicago The Robert J. Gunterberg Charitable Foundation Daniel M. Rose, MD Selma Rose
PULMONARY FIBROSIS FOUNDATION
Manufacturing Co., Inc.
William A. Inglehart Revocable Trust
Booz Allen Hamilton
Henry M. Staley Charitable Trust
16
Tighe Logistics Group
Lawrence Rosenzweig Romalda Schwed Sally Willis
Jennifer A. Galvin, MD Michael C. & Donna Henderson Ikaria, Inc. ImmuneWorks Jennifer Marie Jardine John & Dolores Kent Maxine Kent Callinan Wade Lange Chuck Lawless / The Lawless Team, Mesirow Financial Warren & Denise Loveland Nederlander Organization, Inc. Sonny & Dana Nuccio Julia Willis O’Connor Vania & Barbara O’Connor Pacific Northwest Friends of the PFF Carl & Teresa Salzano The Shubert Organization, Inc.
$1,000–$2,499 Robert Abrams Alamance Force Volleyball Club Barbara Albert The Allstate Giving Campaign ( NJ ) American Society for Quality Ameriprise Financial Employee Giving Campaign Anna M. & James L. Kirk Foundation, Inc. Robert Arnold Avon American Legion Post 145 B2B Marketing Group, Inc.
Bonnie Bannister Michael & Colleen Barbarita Beth Bearance Harry Beardsley Bellingham Elks Lodge #194 Daniel Beren, Esq
the Archdiocese of New York Richard Chambers Chicago Area CFC Children’s Network Corporation Jo Carol Clark Clemons Builders Clyde & Anita Becker Foundation, Inc. Sandra Cohn & Family Bernard Costello Andrea Coughlin-Rubio Cushing & Dolan, P.C. John Daly Verdell Daniels Lance & Diane Darga Kathryn Davis John M. DeMichaelis & Family Ronda Dorchester Educational Data Systems, Inc. Marlene Embry
supporting growth
Austin Esecson
Michael Hupy
George Etzweiler
IBM Employee Services Center
Brandy Fanter
Mary Jack
Fidelity Charitable Gift Fund
Herbert Janick, PhD
Sonal Patel
Mike & Leanne Storch
$500–$999
George & Heather Fischer
Chuck & Becky Karlan
Phillips-Van Heusen Foundation, Inc.
Merlin Swackhamer
Amaury Acosta
Five Star Mechanical Corporation
Michael & Linda Keston
Mark Plourde
Claire Tardy
Jennifer Adams & Family
Foley Foundation
James Kuchwara
Puglisi Classico Ltd. Inc.
John Tonner
Cynthia Ajilore
Clifford Forlines
David & Saundra Landsburg
Pulmonary & Critical Care Services, P.C.
Trilogy at Vistancia
Natalie Allen
Former Clerks & Staff of the Honorable
Alan Lazzard
Debbie Purcell
Roger Lee
Kathleen & Tom Reed
Thomas Lehrer
Mike & Maureen Reed
Jonathan Locker
Jim Demasi & Mary Reghetti
University of Rochester
Representative Brian Baird, PhD
Chuck & Char Fowler
Kitty Lopez
John Rickert
Unum Group
Richard & Sharon Bartley
Herbert Gedge
M.J. Murdock Charitable Trust
Becky Riddle
John Valenti
Rebecca Bascom, MD, MPH
Girlfriends Charity Christmas Auction
Mayo Clinic
Franklin Rose, MD
Doris Virden
Belle Battista
Gordon and Betty Moore Foundation
Art McCoy
The Royalty Trust
Scott Stiglitz & Pam Visser
Bay Area Medical Center
Genevieve Grayeski
Medical Anesthesiology Associates, P.C.
Schwab Charitable Fund
H.R. Wainwright
The Bay State Federal Savings
Great Friends Charities
Microsoft Matching Gift Program
Alan & Pam Schwed
Milton Walsey
Vikash Gulati
Stephen Monas
Chaye Shapot
WB-BR Kiwanis Foundation
Bernice Bechard
Lisa Hardiman
Monroe Wheelchair
Ray Shelmire
Welsh Charitable Trust
Shirley L. Becker
The Hart Family – Orepac Foundation
Charles & Elise Morris
David Sherry
The WGR Foundation
Ross Berbeco
Curran & Majorie Harvey
Richard Nelson
Harold Slagle
Roger Wilander
Michael Bettis
Carla Helaszek
Night Gallery Bar
Carol Smith
Rufus & Sheila Williams
Paul & Linda Bickel
Veronica Herek
Robert O’Meara
Warren Smith
Jonathan Witt
Timothy S. Blackwell, MD
Holson Family Foundation
Carol Paczkowski
So Hum Foundation
The Winfield Foundation
Gina Blea
Ruth Homan
Laura Palagyi & Family
David Spaulding
Rick Wollenberg
Caroline & Erik Bloss
Bill Hopfinger
Thomas Panaggio
Chris Spilios
Richard F. Zegarra, MD
Greg Blus
Horizon Hospice & Palliative Care
Nayankishor Pandya
Robert & Amy Starling
Steve & Bev Hossa
Raman Patel
Terence Evans Foundation for Art Research & Education, Inc.
Community Association Unitarian Universalist Westside Congregation
Elizabeth Ames Guy Armstrong Forrest Bailey
Charitable Foundation
Jean A. Boenitz Jagadish Boggavarapu
2011 ANNUAL REPORT
17
2011 SUPPORTERS $500–$999 (continued)
Marsha East
Buz Hoffman
Meredith Mann
William Perpich
Chris Boneau
Robert East
Hans Holland
Todd & Caroline Marchant
Peru Pharmacy, Inc.
Kevin K. Brown, MD
Helen Entrican
Charles & Jody Howard
Mariani Nut Company Foundation, Inc.
Deana Peterson
Adrian Bryan-Brown
Dan & Terri Evered
Indiana Council of Community
James Martin
Dorothy Phipps
MaryAnn Buttweiler
Louise Ewing
Matthew Henson School National
Pitney Bowes Software, Inc.
Caesars Entertainment Operating
Jeffrey Farnsworth
J. Reckner Associates, Inc.
Bob Feller
Mary Jackson, MD
Shawn McCallister
Thomas Postek
Calkins Electric Supply Co., Inc.
Heather Fergeson
The Janet & Tony Goldman
Florence McErlane
Proskauer Rose LLP
Harry & Kris Campbell
First Rate, Inc.
Margaret McKane
Proud Eagle, Inc.
Carrico Aquatic Resources, Inc.
Katherine Flahive
Karon Johnson
Johnny Mendoza
Kerin Rausch
Casella Waste Systems, Inc.
Katherine Frank
Monica Joshi
Merck Partnership for Giving
James & June Reed
CDW
James & Susan Galluzzo-Rosati
Paul Julien
Mesirow Financial
The Regence Employee Giving Campaign
Champlain Valley Physicians Hospital
Dave Delgado and Lisa Gammon
Michael Kamdar
David Meyer
RGL Consultants
Lisa Gardini
David W. Kamp, MD
Sam Michaels
David Riley, MD
George Chew & Family
Sandra Garfinkel
Anne Kampmeier
Edward & Carole Miller
Bryan Rogers
Terrence Chew, MD
Genentech Givingstation
Luanne Kane
John & Linda Miller
Art Ross
Jason Chien, MD
Wendy Gerber
Sharon Karlin
James Montano
Bill Rouine
Clark CARES Foundation
Give with Liberty Employee Donations
Ron Keil
Marci Moon
Mary Rouine
Lance Clark, Sr.
Goldman Properties USA , Inc.
Knight Automotive, Inc.
Jennifer Morgan
Steven Sahn, MD
Scott Cohen
Steven Gordon
Koppelman Family Foundation
The Mount Airy Knitters
Takefumi Saito, MD, PhD
Community Health Charities of Nebraska
Clifford Greene
Shimon Korish, MD
Brian Mozhdehi
Mitchell Schear
Esperet Corinne
Steve & Elizabeth Griffith
Jonnie Kuchwara
George Nauyok
Frances Schwindt
Gregory P. Cosgrove, MD
Haddon House Food Products, Inc.
Edward & Rose Kuhn
Terry & Diana Nelson
Valerie Scott
Coughlin/Rubio
Halliburton’s Giving Choices
John Lambert
Neshaminy Constructors, Inc.
Margaret Severson
CRW Parts, Inc.
Employer Match Program
Stephen Lanzendorf
Bobbi Newman
Wallace & Janet Sharp
Company, Inc.
Medical Center
18
Mental Health Centers
Take A. Risk Foundation
Junior Honor Society
Hope Plasha
Wendy Cubbon
Phillip & Irene Halper
Sandra Lehigh & Family
Allan Noddle
Tom Shen
Joseph DeGrazia, Jr.
Helen Jane Hamilton
Mary Lewis
Kurt Noyce
Patricia J. Sime, MD
Perry Deitrick
Sally Hansen
Thomas Link
Elizabeth & Michael O’Brien
Ann Smith
Thakor & Bharti Desai
The Haskell Company
LTD Truck Repair, Inc.
Joseph & Carolyn O’Leary
Cecilia Smith, MD
Gina DiBella
Steven Doloff and Susan Haskins
Edward & Sharon Luikaart
Thomas O’Riordan, MD
James Solomon
Peter Diconza
Hays Companies
Mary Lujan
Linda Osterman
Bill Sorenson
Jill Dion
Health Alliance Plan of Michigan
Melissa Lujan Ascencio
Judy O’Sullivan
Christina Soubrane
Carlinda Dirks
Christine Heckford
Barbara Lynn
Bert Oyama
Source Atlantique, Inc.
Anne Donahoe
Nancy Heitmeyer
Frank P. Maltese, Jr.
The Pastene Companies, Ltd.
Ken Spraetz
Gwenyth Duhn
Kathy Hockemeyer
Edward Mann
Rafael Perez, MD
Robert St. Germain
PULMONARY FIBROSIS FOUNDATION
St. Martin of Tours School
$250–$499
William & Mary Beargie
Michael Bushee
David Dalton
Ira & Pat Stein
ABARTA Oil & Gas Co., Inc.
Joyce Beck
Percy Calkins
Isabelle Dearmond
James Stoller
Advanced Animations, LLC
H. Douglas Bedinger
Rose Cannata
Jerome DeGroote
James Strohl
Patrick & Katy Ahern
Heather Behanna
John Capellupo
Timothy DeGroote
Brian Sullivan
Lori Ajmo
Rowland Bell
Linda Carpenter
L. Michael Delgado
Sunrise Commodities, Inc.
Thomas Akey, MD
Jean Bentel & Family
Marybeth Caruso
Samuel Delibert
Mary Ellen Supon
Patricia Alanis
Gidon Berger
Robert Case
Alfred & Susan Demaria
Mark Surber, MD
Ted & Irene Alessio & Family
Monique G. Bergeron
Viviane & Adam Cashman
Deutsche Bank Americas Foundation
Samuel Tambyraja, MD
Dwight Allbee & Family
Tamra Bernard Sanchez
James Cassata
Team Mossman Events LLC
Kari Alyea
Barbra Berry
Jessica Castle
Michael Deverell
Terrier Claims Services
America’s Charities Distribution Account
David Berzon, MD
Rosemary Cauley
Randee Dewey
Fred Thomas
Vinny Andaloro
Jila Bick
Mary Celenza
Barb Diggins
Leah Tobin, MD
Javier Apilanez Tomas, MD
Jack Bingleman
Herb Chain
Daniel Dilling, MD
Earl & Bunny Toledo
Arizona State University
Stephen Blacker
Andrew Chan
Anne Dimmock
Barry Blaine
Chevron Humankind – Matching Gift /
Diversified Information Technologies
Earle Traub
Alumni Association
Employee Funds
Matching Gifts Programs
Roy Tucker
John David Armstrong, MD
Robert Bloom, MD
U.S. IOL, Inc.
Terry, Lise & Len at MGO
Leonard Bologna
Terri Christenson
D.L.S. Enterprises
Lionel Doss
United Way of Allegheny County
Arrow Exterminators
Boston Capital Foundation
James Chuck
Elliott Dowling
United Way of Delaware
Autumn Village, LLC
Jennifer Bottalico
Raymond Ciccarelli
David & Mary Druker
Universal Orlando Resort
Roobina Baghoomians
Kent Bowman
Jose Cisneros
Drywall Unlimited Corp.
Voco America, Inc.
Dale Baird
Williamson Bradford, MD, PhD
Julie Clark
Marlo & Vernetta Dummann
Michael Wade
Peter & Susan Baker
Laurie Brewster
Karen Clark
Gary Dunham
Warner Manufacturing Company
Diana Bamford-Rees
Bridgeport Hospital, CT
Ron & Ann Clark
Kevin Dushay, MD
Howard Watt
Masashi Bando
John & Kendra Bridges
John Cole
Lynda Dutton
Charles & Karen Westphal
Bank of America
Dorothy Brooks
Harold R. Collard, MD
Steve & Marivern Easton
James & Brenda White
Bob & Mary Beth Barber
Annette Brown
Rany Condos, MD
Eileen Eberhart
Mary Wieteski
Bettylou Bargo
Brown Deer Seniors Golf Club
Margaret Conlon
Katarine Egressy, MD, MPH
Judith Williams
Cathy Barr
Donna Brucoli
Thomas & Mary Cooley
Elizabeth Elliott
Jennifer Wilson
Bill Bartholomew
Tedryl Bumpass
Phillip & Kathleen Cooper
Hal Elsasser
Lynn Witowski
Rona Bartholomew
Sybil-Ann Burgess
Michael Corn
Emerald Society MTA – NYC Transit
Julia Yaeger
Peter & Susan Barylski
Lisa Burke
James Couser, MD
Employees of Clayton Group
Thomas Youngs
Steven Basile
Joseph Burkhart
Cowan Community School Corporation
Steve Zeiger
Baxter Employee Giving Campaign
Linda Burkly
Judy Crandall
James English
Joseph Zibrak, MD
Cyndi Beach
Stanley & Sherri Burton
Csilla Csoboth, MD, PhD
Kristi Esker, FNP
Lillian K. Zuckerman
Edward Beach
Charles Busch
Beverly Cudmore Kraus
Sally Etz
& Vantage Finance
2011 ANNUAL REPORT
19
2011 SUPPORTERS
20
$250–$499 (continued)
Doug Goodman
Jessica Hirt
Lisa Rubin Kates
Noel Lambert Morrissey
Susan Evers, RN
Eduard Gorina, MD
Jennifer Hodge
Michael Kavanaugh
David & Kathryn Langevin
Cheryl Ewart
Starr Graff
Jack Hogg
Pat & Pam Kearney
John & Margaret Langford
Jerome Facher
Meg Grant
Bob & Marti Hopper
Jan Kelly
Joseph Lasky, MD
Elizabeth Fagan, MD
Susan Gravelyn, MD
Michael Horton
Richard Kelly
Stephanie Lau, MD
Leslie Farolan
Deborah Green
Riley Howard
David Kelso
Bobbie Lawson
Jacob Feinstein
Sue Greninger
HSBC Philanthropic Programs
Donald & Nancy Kennedy
Jacques Le Sourd
Robert & Nancy Feldman
Ted Gronski, MD
Jay Kenney
Terrie Leake
Edward Felter
Grotto Pizza
David Kim & Jin Hu
Kenneth Kerr
John Leavey
Scott Fineron
Michael Grupka
Howard Huang, MD
Dolly Kervitsky, RCP, CCRC
Joyce Lee
Employees at First Quality Nonwovens
Rae Ellen Gutrich
John Hunt
Sanjay Keswani, MD
Lenox Hill Hospital
Sean Flanagan
Dan & Meg Hack
Hemingway Huynh
Nasreen Khalil, MD
Colm Leonard
Fluor Employee Giving Campaign
Haddon Renal Medical Specialists
InCryo Systems, Inc.
Daniel Killinger
Menasha Corporation
FM Global Foundation
Larry Hagfors
Bill & Margaret Ismon
Jim Killinger
Melissa Fogelberg
Suzanne Hale
Jane Jackman, MD
Matthew Killinger
Deborah Lewis
John & Nancy Foppiano
Debby Ham
Steven Jackman, MD
Scott Killinger
Jeffrey Lieb
Jessa Ford
Mark Hamblin
Jackson National Life Insurance
Hyun Kim
Gregory Liedtka
Patrick Fowler
Becky Hamilton
Ross & Janet Kimmerle
Vincent Lombardini
Franks ‘N’ Dawgs
Jarmilka Hanek
Katherine Jahnes
Gary Kindt, MD
Roger Long
Eleanor Freeman
James Hanna
Jim & Jean James
Jeffrey & Heather King
Craig Longfield
Liv Margareth Cook Froiland
Gerhard Hannig
The Janus Foundation
Shirley King
Kathryn Lucas
Kimberly Ganley
James Haran
Mark Jaros
Talmadge E. King, Jr., MD
Todd Luczak
Patricia GaNun
Randall Harris, MD
Sharon Jenkins
Kiwanis Club of Hampton – Midtown
Jamson & Katherine Lwebuga-Mukasa
Tricia GaNun Guyon
Brad Hart
Jim Jordan & Associates, LP
Elizabeth Klein
Cheryl Lynch-Brady
Christine Kim Garcia, MD, PhD
Jeffrey Hartung
JMJ Consulting, Inc.
Leila Klein
Marco Polo Macias, MD
Jeffrey Gaus
Dean Haskins
Christopher Johnson
James Knoble
Debbie Macomber
Felecia Gelvin
Maryann Hatfield
Oscar Johnson
Rupert Koblegarde
Joyce Magnus
Mary Alice Gerhardt
John & Patty Hebert Agnew
Johnson & Johnson
Andrea Kopsa
Gary Malasky
Barry & Merle Ginsburg
Gary & Linda Henderson
Kay Lynn Kretchmar
Dawn Malatia
David Gioiella
Jeff Henderson
Pat & Bob Jones
Barbara Krongel
Bradley Malkus
Sharon Gjertsen
Mary Hennessy
Claude Jourdan Le Saux
Evadna Kronquist
Antoinette Mandich
Peter Glazer
David Herder
Scott & Rebecca Kaiser
Barbara Krugh
Peter Marchant & Family
Global Impact
Laura Highmark
William Kane
Tom Kulczycki
Charles Marchese
Jeff Golden, MD
Monika Hill
Kaplan Career Institute
James Laev
Amy Margolis
Elizabeth Gonzalez
John Hilliker
Robert Karman, MD
Timothy Lally
John Marhoefer
PULMONARY FIBROSIS FOUNDATION
Matching Gift Program
Company
Matching Gifts Program
Leverage Point Media
Alicia Martin
Anne Minnich
Andre Maske
Renee Minogue
MasterBrand Cabinets, Inc.
Sandy Mohan
Eva Mate, MD
Oracle Corporation
Allan Reagan
Mary Beth Scholand
REIT Management & Research LLC
Marty Schubilske
William Osterbauer
Richard Gray Gallery
Katherine Schwandt
Roger Monks
Rupak & Srividya Pandya
Richard T. and Kirsten E. Liebhaber
Donna M. Schwartz
Mary Beth Mateer
Jason Montano
Claudio Pasquinelli
Peter Matson
A. Bruce Montgomery, MD
Matthew Enterprises, Inc.
Matching Gifts Program
Family Foundation
Helen Schwartz
Daniel Patricia
Thomas Richards, PhD
Eileen Scoville
Deborah Morgan
Carolyn Paulson
James & Melissa Rinzler
Luis Septien, MD
James & Joanne Mattiucci
Carmen Moure
James Pearl, MD
Patton Roark
Paula Severson
Juan Antonio Mazzei, MD
Maria Moure
Ruth Peck
Alexa Robbins
Anita Shah
Mariano Mazzei, MD
Ronald Mundt
Sanaz Pentz
Ken & Carol Roberts
Steve and Linda Shaw
James McArthur
Eric Munro
Carlos Pereira
Pedro J. Marcos Rodriguez, MD
Barry Shea, MD
Tracy & Sheryl McAtee
Thomas Munzel, MD
Tamra Perez, BSN
Anne Romano
Ronald Shellan
Ed McCarthy
Murphy’s Bar
David Perlman, MD
Stephen F. Rooney
Anthony Shen
McCormack Distributing Co.
Ellen Muzi
Kathleen Perpich
Anthony & Christina Rose
Adrian Shifren, MBBCh
Ross & Elisabeth McCoy
Bruce Myers
Catherine Persichini
Eric Rosencrans
Sue Shoemaker
Kathleen McDougall-Lowe
Anoop Nambiar, MD
Peru Central School Federal
Bruce Rosenzweig
Cara Schillinger
Rob McFadden, MD
Marian Nasgovitz
Barbara Ruff
Revati Shreeniwas, MD
Robert McIvor
National Philanthropic Trust
Jay Peters
Heather Runnette
David Shukis
Lisa McKelvie
E. Robert & Phyllis Newman
The Pfizer Foundation
Marilyn Russell
V. Irene Siano
James McLellan
Murray & Sherry Newman
Tonya Russell, MD
Richard Siegel
John McMichael
Guy & Rebecca Nielsen
Diane C. Pirner
Bill & Cathy Ryan
Paul Simonelli, MD
Karen Medema & Family
Diane Nielson
Phillip Plante
John Ryan
Nicholas & Laura Skadsberg
Medical of Dubois, Inc.
Richard Nielson
Drew Pomerance
Maureen Salitis
Kevin & Becki Slanicky
Medical Staff at the Vista
Rondiene Novitz
Ken & Sue Poorman
Andrea Sambatti
William Slattery
Reeva Nowitz & Family
Seth Porter
JoAnne Samila
Marilyn Smith
Paul & Peggy Meillier
Courtney Nuccio
Jose Portugal
Donald & Elizabeth Sands
Tommy & Julie Smith & Family
Joseph Meindl
Noel Nutting
Steve & Glynis Potts
Rosemary Schatzman
Steven Solimano
Keith Meyer, MD, MS
Sean O’Quinn
Alan & Sandra Pratt
Patricia Schick
The Smeltzer Companies, Inc.
Middle Tennessee State University
o2totes
Heidi Prestash
Kevin Schiffler
Stephen Spalding
Obermayer Rebmann Maxwell
William & Linda Price
Kathleen Schlenker
Christopher Spaulding
The Private Bank
Rozsa Schlenker-Herceg
Heike Specht
Health System
Dept. of Chemistry Patricia Mikes, MD
& Hippel LLP
Credit Union
Matching Gifts Program
Cathi Miller
Marwan Obid, MD
Pulmonary & Allergy Associates
Ron & Jackie Schmid
Paul Spillane
David Miller
Carol O’Donnell
Sarah Ramey
Schneider Packaging Equipment Co., Inc.
Joseph Squicciarino
David L. Miller
Steven Olmsted
Range Resources Corporation
Robert Schnieders
Terry St. Germain
Michelle Miller
Jennifer O’Neill
RE/MAX North Country
Bradley & Christine Schofield
Mark Stanley
2011 ANNUAL REPORT
21
2011 SUPPORTERS
2011 TEAM PFF EVENT COORDINATORS
$250–$499 (continued)
United Way California Capital Region
Daniel & Kimberly Stargatt
United Way of New York City
Scott Staszak
University of Chicago
Elsie Yardley
Squirrels Bacanskas & Terpnuts
Richard Vander Horst
Justin Yee
Paul Venizelos, MD
Harvey & Donna Yost
Ruth LaClair
Jeff Kramer
Viele, Solimano, Swagler,
Robert Young
Barbara Murphy
Jack Lim
Statler & Family Betty Stephens Angela Stephenso
& Chapman CPA s
at Global Crossing
Claudette Zaccardi
Stonebridge Women’s Club
Village Bank
Christine Zarndt
Jerry & Suzanne Stott
Steve Virden
Larry & Sandy Zentz
Kathy Strandboge
William & Catherine Vollmer
ZF Industries, Inc.
Claire Stull
Elliot & Joan Walsey
Yingze Zhang
Sturdy Savings Bank
Eugene Walter
Cathi & Dave Zotter
Collette Sullivan
Guifang Wang
Edward E. Zwig
David & Mary Sullivan
Kathleen Ward
Von & Barbara Summers
Alan Watson
Krishna Sundar
Richard Watson
T & R Black’s Hardware, Inc.
James Watt
Andrew Tager, MD
Marian Watt
Sara Talley
Mike Watt
Arunabh Talwar
Jennifer Watters
Carolanne Tarby
Leslie Watters, MD
Emilia Theodoridou
Patricia Webb
Roger & Jan Titus
David Weiner
Town & Country Ford, Inc.
Peter Werner, MD
TSBL Distributing
Lewis Wesselius, MD
William Tsoi
Ralph White, MD
Hollis Tucker
Thomas & Stathy White
Neal Tully
Mark & Vickie Wilchinsky
Patti Tuomey, EdD
Jonathan Wilde
Harry Turvey
W.R. & Darlene Willard
Unilever United States Foundation, Inc.
Janice Wilson
United Consulting
Brent Winston
United Health Group ( NJ )
Deborah Witt Melanie Wolfe
22
Worldwide Carrier Services CFU
PULMONARY FIBROSIS FOUNDATION
$25,000–$49,999
$500–$4,999
Nick DeVito
Joseph DeGrazia, Jr.
D. Michael Dvorchak, Sue Frost,
Brenda Harvieux
Julie Halston, & Ed Windels
$5,000–$24,999 Debbie Adams Cindy Chandler Justin Domingos Robert & Jackie Fiorillo First Midwest Bank Liz Griffith Cheryl Hampton
2011 IN-KIND SUPPORTERS Booz Allen Hamilton Bulldog Bakery Dan Development Foiled Cupcakes Hogan Lovells Sandra Bean Lewis Lincare Kate Magrino, MA , LCPC Microsoft Susan M. Murphy National Jewish Health ProVideo Jesse Roman, MD Squigs’ Ink The France Foundation Timre Surrey Photography Wodka Vodka
Luanne Kane & Connie Kleinfelter Deb Lewin Sonny & Dana Nuccio
Jerry McClellan & Ted Keller
Joseph Lore, Jr. Melissa Lujan Ascencio Margo Miller & Marci Moon Donna Mullins Mary Novel Jimmy Pelletier Courtney Firak & Michelle Peters Jasmin Powell Scott Stiglitz & Pam Visser Karen Wesphal Dave Willacker
Kelly Partenheimer
$300–$499
Kim Perry
Joe Bonavita
Cindi Petri-Hendry
Nancy Neil
Judy Smith
Alicia Vasquez
Stephen Spahr Nancy Liva & Michelle Sullivan Lisa Tighe Tammy Walker Elliot Walsey Beth Walsh
2011 CORPORATE GRANTS Amira Pharmaceuticals, Inc. Gilead Sciences, Inc. InterMune
Financial Summary
3% INVESTMENT INCOME 3% PROGRAM SERVICE FEES 16% FUNDRAISING
8% OTHER REVENUES
14% MANAGEMENT
STATEMENT OF FINANCIAL POSITION
AND GENERAL
AUDITED NUMBERS
Total Assets Total Liabilities
2011 2010 3,511,296 3,555,331 152,316 23,147
Total Net Assets
3,358,980
3,532,184 70% PROGRAM SERVICES
86% PUBLIC SUPPORT
STATEMENT OF ACTIVITIES
ALLOCATION OF 2011 EXPENSES
SOURCES OF 2011 REVENUE
AUDITED NUMBERS
AUDITED NUMBERS
Public Support Program Service Fees Other Revenues Investment Income
1,950,159 70,555 178,277 56,123
86% 3% 8% 3%
Total 2011 Revenue
2,255,114
100%
Total Revenue Unrestricted Temporarily Restricted Total Expenses Loss on disposal of property and equipment Change in Net Assets
2011 2,157,840 97,274
2010 1,659,871 (5,000 )
2,255,114
1,654,871
2,425,673
1,137,471
(2,645 )
0
(173,204 )
517,400
Program Services by Category Advocacy 122,676 Physician and Patient Education 119,480 Research 364,254 Affiliates 25,745 Patient Outreach 114,450 Registry 25,084 Summit 913,718 Program Services Total Management and General Fundraising
1,685,407 70% 348,943 14% 391,323 16%
Total 2011 Expenses
2,425,673
100%
2011 ANNUAL REPORT
23
MEDICAL ADVISORY BOARD Kevin K. Brown, MD*
STAFF
CHAIRMAN
Daniel M. Rose, MD* PRESIDENT AND CEO
Patti Tuomey, EdD* CHIEF OPERATING OFFICER
Joseph Borus, Esq*
Daniel M. Rose, MD
David W. Kamp, MD
PRESIDENT AND CEO
MEDICAL DIRECTOR
Patti Tuomey, EdD
Jesse Roman, MD* CHAIRMAN, RESEARCH ADVISORY COMMITTEE
Dolly Kervitsky, RCP, CCRC
Marvin I. Schwarz, MD
VICE PRESIDENT, PATIENT REL ATIONS
PAST CHAIRMAN
Cara Schillinger
Timothy S. Blackwell, MD*
David Lynch, MD
Jeffrey T. Chapman, MD
Fernando J. Martinez, MD, MS*
COMMUNICATIONS AND MARKETING
TREASURER
Harold R. Collard, MD
A. Bruce Montgomery, MD
Scott Staszak
Ritu S. Baral*
Rany Condos, MD
Imre Noth, MD
CHIEF FINANCIAL OFFICER
Daniel Beren, Esq
Gregory P. Cosgrove, MD
Ralph J. Panos, MD
Jennifer A. Galvin, MD
Aryeh Fischer, MD
Ganesh Raghu, MD
Jennifer Bulandr
Courtney Firak
Michael C. Henderson*
Christine Kim Garcia, MD, PhD
Luca Richeldi, MD, PhD
DIRECTOR,
COORDINATOR,
COMMUNITY AFFAIRS
SUPPORT SERVICES
Daeshawna Cook
Meredith D. Mann
COORDINATOR,
DIRECTOR,
COMMUNITY EVENTS
RESOURCE DEVELOPMENT
SECRETARY
Thomas E. Hales*
Sandra Bean Lewis
Andreas Günther, MD
Glenn D. Rosen, MD
Julia Willis O’Connor
Susan S. Jacobs, RN, MS
Patricia J. Sime, MD*
ASSOCIATE VICE PRESIDENT,
AND ASSOCIATE VICE PRESIDENT, INFORMATION TECHNOLOGY
John Ryan
Naftali Kaminski, MD*
David A. Schwartz, MD*
Carl Salzano
Joseph Lasky, MD*
Moisés Eduardo Selman Lama, MD
Zoë Dirks
Amanda B. Miller
Stephen A. Wald, PhD
Andrew H. Limper, MD*
Charlie Strange III, MD
SENIOR PROJECT MANAGER
COORDINATOR, DEVELOPMENT
Matthew C. Williams
Kathleen Lindell, PhD, RN
Robert Strieter, MD*
Wendy Escobar
Elizabeth Price
Jeffery J. Swigris, DO, MS
COORDINATOR,
MANAGER, DATABASE
FINANCIAL OPERATIONS
ADMINISTRATION
James E. Loyd, MD* *E XECUTIVE COMMITTEE
Janet Talbert, MS, CGC *RESEARCH ADVISORY COMMITTEE
24
CHIEF OPERATING OFFICER
PULMONARY FIBROSIS FOUNDATION
DESIGN: BOCKOS DESIGN, INC.
BOARD MEMBERS
The mission of the Pulmonary Fibrosis Foundation is to help find a cure for idiopathic pulmonary fibrosis, advocate for the pulmonary fibrosis community, promote disease awareness, and provide a compassionate environment for patients and their families.
www.pulmonaryfibrosis.org